Literature DB >> 6199512

Interferon-induced 2-5A synthetase activity in human peripheral blood mononuclear cells after immunization with influenza virus and rubella virus vaccines.

L J Penn, B R Williams.   

Abstract

The interferon-induced enzyme 2-5A synthetase can be a sensitive indicator of activation of the human interferon system during viral infection or interferon therapy. To determine the response of the human interferon system to viral antigens, the level of 2-5A synthetase activity was monitored in peripheral blood mononuclear cells of healthy adults before and after immunization with influenza or rubella virus vaccine. The influenza virus-vaccinated individuals demonstrated increases in enzyme activity on days 1 and 11 in vivo, whereas those vaccinated with rubella virus vaccine showed an increase only on day 11. The difference in the day 1 in vivo 2-5A synthetase response in the two vaccinated groups could be demonstrated by in vitro incubations of peripheral blood mononuclear cells isolated approximately 90 days postvaccination with the two vaccines. The day 11 increase of enzyme activity in the rubella virus group showed a positive correlation with an increase in serum antibody titer, suggesting activation of the interferon system during antibody production in vivo after human exposure to virus antigens. The demonstration of increased 2-5A synthetase activity at specific times postimmunization in this investigation indicates that the interferon system is involved in the human in vivo response to virus vaccination.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6199512      PMCID: PMC255533     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Increased nuclease activity in cells treated with pppA2'p5'A2'p5' A.

Authors:  A G Hovanessian; J Wood; E Meurs; L Montagnier
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

2.  Natural occurrence of 2-5A in interferon-treated EMC virus-infected L cells.

Authors:  B R Williams; R R Golgher; R E Brown; C S Gilbert; I M Kerr
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

3.  Virus-induced interferon production by human macrophages.

Authors:  N J Roberts; R G Douglas; R M Simons; M E Diamond
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

4.  Inhibition of protein synthesis by 2'-5' linked adenine oligonucleotides in intact cells.

Authors:  B R Williams; I M Kerr
Journal:  Nature       Date:  1978-11-02       Impact factor: 49.962

5.  Rubella viraemia and antibody responses after rubella vaccination and reimmunization.

Authors:  H H Balfour; K E Groth; C K Edelman; D P Amren; J M Best; J E Banatvala
Journal:  Lancet       Date:  1981-05-16       Impact factor: 79.321

6.  Interferon production by human mononuclear leukocytes: differences between respiratory syncytial virus and influenza viruses.

Authors:  T Chonmaitree; N J Roberts; R G Douglas; C B Hall; R L Simons
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

7.  Cell-mediated immune response of human lymphocytes to influenza A/USSR (H1N1) virus infection.

Authors:  A Lazar; P F Wright
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

8.  Mitogen responses and interferon production after exposure of human macrophages to infectious and inactivated influenza viruses.

Authors:  N J Roberts; M E Diamond; R G Douglas; R L Simons; R T Steigbigel
Journal:  J Med Virol       Date:  1980       Impact factor: 2.327

9.  2'5' oligo(A) polymerase activity in serum of mice infected with EMC virus or treated with interferon.

Authors:  I Krishnan; C Baglioni
Journal:  Nature       Date:  1980-06-12       Impact factor: 49.962

10.  Induction of 2',5'-oligoadenylate synthetase and interferon in mouse trigeminal ganglia infected with herpes simplex virus.

Authors:  Y Sokawa; T Ando; Y Ishihara
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

View more
  7 in total

1.  Induction and measurement of 2',5'-oligoadenylate synthetase in Madin-Darby bovine kidney cells and in cattle.

Authors:  E C Short; R W Fulton
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

2.  Production and characterization of a monoclonal antibody to a human interferon-induced double-stranded RNA-binding Mr 68,000 protein kinase.

Authors:  L J Penn; B R Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

3.  SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine.

Authors:  Neelam Dhiman; Iana H Haralambieva; Richard B Kennedy; Robert A Vierkant; Megan M O'Byrne; Inna G Ovsyannikova; Robert M Jacobson; Gregory A Poland
Journal:  Immunogenetics       Date:  2010-03-10       Impact factor: 2.846

4.  Lymphocytic 2',5'-oligoadenylate synthetase activity increases prior to the appearance of neutralizing antibodies and immunoglobulin M and immunoglobulin G antibodies after primary and secondary immunization with yellow fever vaccine.

Authors:  V Bonnevie-Nielsen; I Heron; T P Monath; C H Calisher
Journal:  Clin Diagn Lab Immunol       Date:  1995-05

5.  Injection of mice with antibody to mouse interferon alpha/beta decreases the level of 2'-5' oligoadenylate synthetase in peritoneal macrophages.

Authors:  I Gresser; F Vignaux; F Belardelli; M G Tovey; M T Maunoury
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

6.  2'-5'-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine.

Authors:  Iana H Haralambieva; Neelam Dhiman; Inna G Ovsyannikova; Robert A Vierkant; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Hum Immunol       Date:  2010-01-31       Impact factor: 2.850

7.  Human 2-5A synthetase: characterization of a novel cDNA and corresponding gene structure.

Authors:  M E Saunders; D R Gewert; M E Tugwell; M McMahon; B R Williams
Journal:  EMBO J       Date:  1985-07       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.